SINOCOM PHARMACEUTICAL, INC. — Form D
SINOCOM PHARMACEUTICAL, INC. of CENTRAL, K3, a company, filed a Form D exempt-offering notice with the SEC on 2009-12-14. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2009-12-14
- Form: D
- Accession: 0001137050-09-000287
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $15.0M
- Amount sold: $15.0M
- Investors: 2
- Date of first sale: 2009-12-03
- Security types: equity
- Revenue range: $25,000,001 - $100,000,000
- SEC file number: 021-136867
Issuer
- Name: SINOCOM PHARMACEUTICAL, INC.
- CIK: 0001434017
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2007
- Address: ROOM 3, 21/F, FAR EAST CONSORTIUM BLDG, CENTRAL, K3, 99999
- Phone: 852- 2159-7863
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Xuexiang Kwong Ai | Director | Hong Kong, F4 |
| Tuck Wing Pang | Director | Hong Kong, F4 |
| Chi Kwong Wan | Director | Hong Kong, F4 |
| Xuexiang Kwong Ai | Executive Officer | Hong Kong, F4 |
| Tuck Wing Pang | Executive Officer | Hong Kong, F4 |
More